Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-16-626483
Filing Date
2016-06-20
Accepted
2016-06-20 16:31:16
Documents
5
Effectiveness Date
2016-06-20

Document Format Files

Seq Description Document Type Size
1 S-8 d180991ds8.htm S-8 69160
2 EX-5.1 d180991dex51.htm EX-5.1 6180
3 EX-23.2 d180991dex232.htm EX-23.2 1588
4 EX-99.1 d180991dex991.htm EX-99.1 126684
5 GRAPHIC g180991g13d47.jpg GRAPHIC 8001
  Complete submission text file 0001193125-16-626483.txt   215881
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-212130 | Film No.: 161722468
SIC: 2835 In Vitro & In Vivo Diagnostic Substances